RAPP Buy Disclosure
Ignelzi Troy A. · SEC Form 4 · Filed Oct 21, 2026
Buy
Calculated transaction value
$143.55K
Ignelzi Troy A. Chief Financial Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Oct 21, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed same day
RAPP daily price context
Close on/before transaction
$25.06
Oct 21, 2026
First close after public filing
$26.53
Oct 22, 2026
Return after filing · so far
-2.49%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,500 shares @ $26.1
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-428018
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$143.55K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP Current | Buy | Oct 21, 2026 | $143.55K |